Sex steroids, bone mass, and bone loss - A prospective study of pre-, peri-, and postmenopausal women

被引:239
作者
Slemenda, C
Longcope, C
Peacock, M
Hui, S
Johnston, CC
机构
[1] INDIANA UNIV,SCH MED,DEPT MED,INDIANAPOLIS,IN 46202
[2] UNIV MASSACHUSETTS,DEPT MED,WORCESTER,MA 01605
[3] UNIV MASSACHUSETTS,DEPT OBSTET & GYNECOL,WORCESTER,MA 01605
关键词
estrogens; androgens; sex-hormone binding globulin; osteocalcin; menopause;
D O I
10.1172/JCI118382
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Although bone loss around the time of menopause is driven by estrogen deficiency, the roles of estrogens and androgens in the preservation of skeletal mass at other stages of life are less well understood. To address this issue Re studied 231 women between the ages of 32 and 77 with multiple measurements of sex steroids and bone mass over a period of 2-8 yr, In all women bone mass was negatively associated with concentrations of sex-hormone binding globulin, and positively associated with weight, Bone loss occurred from all skeletal sites in peri- and postmenopausal women, but premenopausal women lost bone only from the hip (-0.3%/yr) and had positive rates of change in the radius and spine, Bone loss was significantly associated with lower androgen concentrations in premenopausal women, and with lower estrogens and androgens in peri- and postmenopausal women, Sex steroids are important for the maintenance of skeletal integrity before menopause, and for as long as 20-25 yr afterwards.
引用
收藏
页码:14 / 21
页数:8
相关论文
共 50 条
[41]   Bone Mass and the Risk of Colon Cancer among Postmenopausal Women The Framingham Study [J].
Zhang, Yuqing ;
Felson, David T. ;
Ellison, R. Curtis ;
Kreger, Bernard E. ;
Schatzkin, Arthur ;
Dorgan, Joanne F. ;
Cupples, L. Adrienne ;
Levy, Daniel ;
Kiel, Douglas P. .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (01) :31-37
[42]   Beneficial effects of pravastatin in peri- and postmenopausal hyperlipidemic women: a 5-year study on serum lipid and sex hormone levels [J].
Ushiroyama, T ;
Ikeda, A ;
Ueki, M .
MATURITAS, 2001, 37 (03) :201-208
[43]   A prospective study of bone loss in menopausal Australian-born women [J].
Guthrie, JR ;
Ebeling, PR ;
Hopper, JL ;
Barrett-Connor, E ;
Dennerstein, L ;
Dudley, EC ;
Burger, HG ;
Wark, JD .
OSTEOPOROSIS INTERNATIONAL, 1998, 8 (03) :282-290
[44]   Bone Metabolism Parameters in Azerbaijani Pre and Postmenopausal Women with Diabetes [J].
Safarova, Sain Sattar .
IRANIAN JOURNAL OF PUBLIC HEALTH, 2023, 52 (02) :334-339
[45]   Cross-sectional and longitudinal assessment of pre- and postmenopausal bone loss with a portable forearm X-ray device: The Ofely study [J].
Duboeuf, F ;
Sornay-Rendu, E ;
Garnero, P ;
Bourgeaud-Lightot, A ;
Delmas, PD .
BONE, 2000, 26 (02) :131-135
[46]   Effects of alendronate and hormone replacement therapy, alone or in combination, on bone mass in postmenopausal women with osteoporosis: a prospective, randomized study [J].
Tiras, MB ;
Noyan, V ;
Yildiz, A ;
Yildirim, M ;
Daya, S .
HUMAN REPRODUCTION, 2000, 15 (10) :2087-2092
[47]   Early decrease in lean mass and bone mass in postmenopausal women: a cross-sectional study [J].
Zandona, J. ;
Ferreira, C. F. ;
de Oliveira, P. G. ;
Ferreira, F. V. ;
Vasconcelos, A. O. ;
Wender, M. C. O. .
CLIMACTERIC, 2022, 25 (01) :96-102
[48]   Bone mineral in pre- and postmenopausal women with insulin-depdendent and non-insulin-dependent diabetes mellitus [J].
Christensen, JO ;
Svendsen, OL .
OSTEOPOROSIS INTERNATIONAL, 1999, 10 (04) :307-311
[49]   High bone turnover is associated with low bone mass and spinal fracture in postmenopausal women [J].
Ravn, P ;
Rix, M ;
Andreassen, H ;
Clemmesen, B ;
Bidstrup, M ;
Gunnes, M .
CALCIFIED TISSUE INTERNATIONAL, 1997, 60 (03) :255-260
[50]   SHORT-TERM EFFECT OF ALENDRONATE ON BONE MASS AND BONE REMODELING IN POSTMENOPAUSAL WOMEN [J].
CHESNUT, CH ;
HARRIS, ST .
OSTEOPOROSIS INTERNATIONAL, 1993, 3 :S17-S19